ARCHIVES

Cancer Groups Endorse Richard Pazdur for Head of FDA’s New Office of Oncology Drug Products. Five Candidates Are In the Running for the Job, Sources Said.

This article is from The Cancer Letter archive.

Vol. 31 No. 07 | February 18, 2005

Download PDF Visit The Full Archive

Related Articles

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980

Breast, Ovarian Cancers Detected Early In Women At High Hereditary Risk

March 29, 2002

BSA Eliminates Second Review For P01 Grants; R01Payline To increase to 24th Percentile

November 23, 1997

House subcommittee’s 5.6% Increase For NIH includes $2.5 Billion for NCI

July 18, 1997

FDA seeks support for reorganization of cancer programs, but debate continues.

July 9, 2004

In Brief: Jefferson Cancer Center Received $10 Million donation, Renamed Kimmel Cancer Center

March 29, 1996